Therapeutic applicability of Zymomonas mobilis on predisposing factors for dyslipidemias and colorectal cancer: A literature review
DOI:
https://doi.org/10.14450/2318-9312.v34.e3.a2022.pp222-229Keywords:
dyslipidemias, colon neoplasm, Zymomonas, fructooligosaccharidesAbstract
Zymomonas mobilis is a Gram-negative, mobile, facultatively anaerobic, and nonpathogenic bacterium that, when fermented from sucrose can produce metabolites with biologically active activities. The present study aims to identify the therapeutic applicability of Z. mobilis on predisposing factors
of dyslipidemia and colorectal cancer through a literature review. Fructose oligomers, levan, and fructooligosaccharides (FOS) are bioactive compounds resulting from sucrose fermentation by Z. mobilis and have been raising interest in their potential therapeutic applications. Levan has immunomodulatory and antitumor actions on the liver and intestinal cells. FOS acts on lipid metabolism, regulating serum cholesterol and low-density lipoprotein (LDL) levels, thus suppressing hepatic steatosis. This probiotic can also trigger a protective eff ect in the colon by inhibiting pathogenic bacteria such as Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Salmonella spp. Due to the ability to control lipid metabolism dysregulation and maintain intestinal microbiota homeostasis, Z. mobilis can be an alternative to conventional drugs for patients presenting chronic diseases, such as dyslipidemia and colorectal neoplasms.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).